BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Production of Recombinant Humanized Anti-HBsAg Fab Fragment from Pichia pastoris by Fermentation

  • Deng, Ning (Lab of Molecular Immunology and Antibody Engineering in Life Science and Technological College, Jinan University) ;
  • Xiang, Junjian (Lab of Molecular Immunology and Antibody Engineering in Life Science and Technological College, Jinan University) ;
  • Zhang, Qing (Life Science School in Zhongshan University) ;
  • Xiong, Sheng (Lab of Molecular Immunology and Antibody Engineering in Life Science and Technological College, Jinan University) ;
  • Chen, Wenyin (The Central Research Institute) ;
  • Rao, Guirong (The Central Research Institute) ;
  • Wang, Xunzhang (Life Science School in Zhongshan University)
  • Published : 2005.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

In this report, we describe the high-yield secretory expression of the recombinant human anti-HBsAg Fab fragment from Pichia pastoris that was achieved by co-integration of the genes encoding the heavy and light chains (both under the control of alcohol oxidase promoter) into the genome of the yeast cells. The fed-batch fermentations were carried out in a 5 L scale. Both chains of the Fab were successfully expressed upon methanol induction. The absorbance ($OD_{600}$) of the broth can reach 350~500 at the end of fed-batch phase. After the induction, the expression level of the recombinant Fab (soluble) reached 420~458 mg/L. The recombinant Fab fragment was purified from the crude culture supernatant by ion exchange chromatography and the purity of the recombinant Fab fragment was over 95%. The affinity activities of the crude fermentation supernatant and the purified Fab were analyzed by indirect ELISA, which showed that the purified recombinant Fab fragment had high affinity activity with hepatitis B surface antigen.

Keywords

References

  1. An, F., Cheng, Y. C. and Fan, L. Y. (2003) Production of recombinant humanized anti-HBs Fab in E. coli by fermentation. Chin. J. Biotechnol. 19, 87-91
  2. Blum, H. E., Wieland, S. and Walter, E. (1998) Nature course of HBV infection; in Hepatitis B Virus, Koshy, R. and Caselmann, W. H. (eds.), pp. 75-92, Imperial College Press, London, United Kingdom
  3. Brierley, R. A., Bussineau, C., Kossan, R., Melton, A. and Siegel, R. S. (1990) Fermentation development of recombinant Pichia pastoris expressing the heterologous gene: Bovine lysozyme. Ann. N. Y. Acad. Sci. 589, 350-362 https://doi.org/10.1111/j.1749-6632.1990.tb24257.x
  4. Chauhan, A. K., Arora, D. and Khanna, N. (1999) A novel feeding strategy for enhanced protein production by fed-batch fermentation in recombinant Pichia pastoris, Process Biochemistry, 34, 139-145 https://doi.org/10.1016/S0032-9592(98)00080-6
  5. Clare, J. J., Rayment, F. B., Ballantine, S. P., Sreekrishna, K. and Romanos, M. A. (1991) High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene, Biotechnol. 9, 455-460 https://doi.org/10.1038/nbt0591-455
  6. Cregg, J. M., Tschopp, J. F., Stillman, C., Siegel, R. and Akong, M. (1987) High level expression and efficient assembly of hepatitis B surface antigen in the methlyotropic yeast Pichia pastoris. Biotechnol. 5, 479-482 https://doi.org/10.1038/nbt0587-479
  7. Cregg, J. M., Vedvich, T. S. and Raschke, W. C. (1993) Recent advance in the expression of foreign genes in pichia Pastoris, Bio/Technol. 11, 905-910 https://doi.org/10.1038/nbt0893-905
  8. Deng, N., Su, K. Y., Wang, X. Z., Long, Q. X. and Yang, L. (2002) Expression of humanized anti-HBsAg Fab fragment in yeast, Chin. J. Biotechnol. 18, 546-550
  9. Deng, N., Xiang, J. J., Wang, X. Z., Chen, W. Y. and Zhang, Q. (2003) Expression, Purification and Characterization of Humanized Anti-HBs Fab fragment, J. Biochem. 134, 813-817 https://doi.org/10.1093/jb/mvg204
  10. Digan, M. E., Lair, S., V., Brierley, R. A., Siegel, R. S. and Williams, M. E. (1989) Continuous production of a novel lysozyme via secretion from the yeast Pichia pastoris, Bio/ Technology, 7, 160-164 https://doi.org/10.1038/nbt0289-160
  11. Dulbecco, R. and Ginsberg, H. S. (1980) Immune response to viral infection; in Virology, Davis, B. D., Eisen, H. N. and Ginsberge, H. S. (eds.), Harper and Row, New York, USA
  12. Files, D., Ogawa, M., Scaman, C. H. and Baldwin, S. A. (2001) A Pichia pastoris fermentation process for producing highlevel of recombinant human cyctatin-C. Enzyme Microb. Technol. 29, 335-340 https://doi.org/10.1016/S0141-0229(01)00395-7
  13. Johnstone, A. and Thorpe, R. (1982) Affinity purification methods; in Immunochemistry in Practice, Johnstone, A. and Thorpe, R. (eds.), pp. 905-909, Blachwell Scientific Publication, Oxford, United Kingdom
  14. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680- 685 https://doi.org/10.1038/227680a0
  15. Lange, S., Schmitt, J. and Schmid, R. D. (2001) High-yield expression of the recombinant, atrazine-specific Fab fragment K411B by the methylotrophic yeast, Pichia pastoris. J. Immunol. Methods 255, 103-114 https://doi.org/10.1016/S0022-1759(01)00351-9
  16. Levy, R. and Miller, R. A. (1983) Tumor therapy with monoclonal antibodies. Fed. Proc. 42, 2650-2656
  17. Maeda, F., Nagatsuka, Y. and Ihara, S. (1999) Bacterial expression of a human recombinant monoclonal antibody Fab fragment against hepatitis B surface antigen. J. Med. Virol. 58, 338-345 https://doi.org/10.1002/(SICI)1096-9071(199908)58:4<338::AID-JMV4>3.0.CO;2-5
  18. Muller, R., Gubernatic, G. and Farle, M., (1991) Liver transplantation in HBs antigen (HBsAg) carriers prevention of hepatitis B virus (HBV) recurrence by passive immunization. J. Hapatol. 13, 90-96 https://doi.org/10.1016/0168-8278(91)90869-D
  19. Sambrook J., Pritsch E. F. and Maniais T. (1989) Molecular Cloning, A Laboratory Mmanual, 2nd ed., Cold Spring Harbor Laboratory Press, New York, USA
  20. Seef, L. B. (1984) Strategies for passive and active prophylaxis; in Viral Hepatitis and Liver Disease, Vyas, G. N., Dienstag, J. L. and Hoofnagle, J. H. (eds.), pp. 537-542, Grune and Stratton, Orlando, USA
  21. Takahashi, K., Yuuki, T. and Takai, T. (2000) Production of humanized Fab fragment against human high affinity IgE receptor in Pichia pastoris, Biosci. Biotechnol. Biochem. 64, 2138-2144 https://doi.org/10.1271/bbb.64.2138
  22. Tam, M. R. and Goldstein, L. C. (1985) In vitro diagnostic test; in Manual of Clinical Microbiology, Lennette, E. H., Balows, A. and Hausler, W. J. (eds.), pp. 905-909, Am. Soc. Microbiol., Washington, USA
  23. Tschopp, J. F., Sverlow, G., Kosson, R., Craig, W. and Grinna, L. (1987) High level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. Bio/Technol. 5, 1305- 1308 https://doi.org/10.1038/nbt1287-1305
  24. Tschopp, J. F., Brust, P. F. Cregg, J. M. Stillman, C. A. and Gingeras, T. K. (1987) Expression of the lacZ gene from two methanol-regulated promoters in Pichia pastoris. Nucleic Acids Res. 15, 3859-3876 https://doi.org/10.1093/nar/15.9.3859
  25. White, D. O. and Fenner, J. F. (1986) Therapeutic and preventive measures of viral infections; in Medical Virology, White, D. O. and Fenner, J. F. (eds.), pp. 278-280, Academic Press, Orlando, USA

Cited by

  1. Double mutation of cell wall proteins CspB and PBP1a increases secretion of the antibody Fab fragment from Corynebacterium glutamicum vol.13, pp.1, 2014, https://doi.org/10.1186/1475-2859-13-56
  2. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity vol.57, pp.1, 2008, https://doi.org/10.1016/j.pep.2007.08.006
  3. Recombinant antibodies: Engineering and production in yeast and bacterial hosts vol.6, pp.1, 2011, https://doi.org/10.1002/biot.201000381
  4. Characterization of deamidation at Asn138 in L-chain of recombinant humanized Fab expressed from Pichia pastoris vol.154, pp.4, 2013, https://doi.org/10.1093/jb/mvt061
  5. Cytochrome b5 reductase–cytochrome b5 as an active P450 redox enzyme system in Phanerochaete chrysosporium: Atypical properties and in vivo evidence of electron transfer capability to CYP63A2 vol.509, pp.1, 2011, https://doi.org/10.1016/j.abb.2011.02.023
  6. Microbials for the production of monoclonal antibodies and antibody fragments vol.32, pp.1, 2014, https://doi.org/10.1016/j.tibtech.2013.10.002
  7. Antibody production with yeasts and filamentous fungi: on the road to large scale? vol.29, pp.2, 2007, https://doi.org/10.1007/s10529-006-9237-x
  8. Kinetic resolution of α-methylbenzylamine by recombinant Pichia pastoris expressing ω-transaminase vol.15, pp.3, 2010, https://doi.org/10.1007/s12257-009-3093-1
  9. Production of humanized F(ab’)2 fragment of rabies blocking antibodies in Pichia pastoris yeast vol.52, pp.4, 2016, https://doi.org/10.1134/S0003683816040165
  10. Enhancing the Production of Fc Fusion Protein in Fed-Batch Fermentation of Pichia pastoris by Design of Experiments vol.23, pp.3, 2008, https://doi.org/10.1021/bp0603199
  11. Challenges to production of antibodies in bacteria and yeast vol.120, pp.5, 2015, https://doi.org/10.1016/j.jbiosc.2015.03.009
  12. Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer vol.107, pp.8, 2016, https://doi.org/10.1111/cas.12981
  13. High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris vol.128, pp.4, 2007, https://doi.org/10.1016/j.jbiotec.2006.12.020